✦ LIBER ✦

PCV67 COST-EFFECTIVENESS OF FONDAPARINUX VS. ENOXAPARIN IN NON-ST-ELEVATION ACUTE CORONARY SYNDROMES IN RUSSIA

✍ Scribed by PA Vorobyev; O Borisenko; M Lesnicheva; S Shiganov; A Lomakin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV47 COST-EFFECTIVENESS OF FONDAPARINUX

✍ C. Pepe; M. Machado; A. Olimpio; M. Canella; R. Ramos 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

Fondaparinux dominates enoxaparin sodium

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 124 KB

Cost-Effectiveness Analysis of Anticoagu

✍ Maxwell, C. B; Holdford, D. A; Crouch, M. A; Patel, D. A 📂 Article 📅 2009 🏛 Harvey Whitney Books Company 🌐 English ⚖ 230 KB

PCV7 THE COST-EFFECTIVENESS OF CLOPIDOGR

✍ A Pietrasik; M Niewada; J Spiesser; S Gabriel 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

PCV63 COST-EFFECTIVENESS ANALYSIS OF CLO

✍ BA van Hout; MJD Tangelder; P Bervoets; S Gabriel 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

PCV4 Comparative Effectiveness Research

✍ Romyen, C.; Chaiyakunapruk, N.; Permsuwan, U. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB